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When endotoxin is injected by vein it is immediately fixed onto platelets (1). 
Both in vivo and in vitro studies have further shown that endotoxin causes 
rapid  aggregation and  disappearance  of blood platelets,  accelerates coagula- 
tion, and promotes release of several intracellular platelet factors with physi- 
ological activity (2-5). It has thus appeared likely that this platelet-endotoxin 
~nteraction may play a role in the earliest phases of removal of endotoxin from 
the blood stream. 
While  a  superficially similar  form of platelet  aggregation  and  release  of 
platelet factors is produced  by thrombin, previous studies have shown that the 
effects of endotoxin and of thrombin on platelets differ in several important 
respects  (6).  The blood of most  mammals  contains  antibodies  to  endotoxin 
(7).  Because antigen-antibody interactions also produce platelet aggregation 
and release of intraceUular components (8-11), the present studies explored the 
thesis that platelet-endotoxin interaction might be a special instance of platelet 
damage by antigen-antibody complexes. These experiments compare the diva- 
lent ion requirements of these two types of platelet injury. They have led to 
the tentative hypothesis that antigen-antibody and endotoxin injury may be 
identical in nature, and secondary to platelet phagocytosis. 
Materials and Methods 
Rabbit blood obtained by cardiac puncture was delivered directly through plastic tubing 
into cold sterile siliconized centrifuge tubes containing anticoagulant solutions to provide a 
final mixture of one part anticoagulant to nine parts blood. Piatelet-rich plasma and platelet- 
poor plasma were prepared by centrifugation as previously  described and contained from 4 to 
8 X 10  s platelets per milliliter (2). Platelet-rich plasma prepared directly from heparinized 
blood contained a much lower  concentration of platelets due to spontaneous  platelet clumping 
in this anticoagulant under the conditions employed. Accordingly,  heparinized platelet-rich 
plasma was prepared by collection  of blood in NaEDTA, preparation of platelet-rich plasma, 
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addition of heparin at this point, and finally, neutralization of NaEDTA by addition of an 
equimolar amount of calcium chloride. 
Material for immunization of rabbits was prepared by emulsifying a 5% saline solution of 
egg alb, rnln  (Ovalbumin 2 X  crystallized, Worthington Biochemicals, Freehold, New Jersey) 
with an  equal volume of complete Freund's  adjuvant  (Difco Laboratories, Inc., Detroit). 
This was administered in three weekly subcutaneous injections of 2 ml, each injection con- 
taining 50 mg of the antigen. Animals were not used until 2 wk after the last injection. 
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FIG. 1. Release of 5HT from platelets  during the course of incubation of platelet-rich  plasma 
(PRP)  with thrombin,  endotoxin,  and  antigen  (platelet-rich plasma  from immunized  ani- 
mals).  Solid bars demonstrate the effects of heparin in these three systems. 
Release of platelet 5-hydroxytryptamine  (5HT)  was  employed as  an index  of platelet 
damage. Allquots of platelet-rich plasma in 10 ml Erlenmeyer flasks were challenged with the 
appropriate additive (endotoxin, egg albumin, or saline), placed on a  12 in. diameter inclined 
rotary disc mixer, and rotated at 28 P.P~ in a 37°C bacteriologic incubator. Samples of plate- 
let-rich plasma were removed at intervals, centrifuged to separate platelets and plasma, and 
the supernatant  platelet-poor plasma  5HT concentration  determined fluorometrically  (12) 
using a  Model A2 Photoelectric Fluorometer (Farrand Optical Co., Inc., New York). Total 
5HT content  of platelet-rich plasma  was determined after  5 cycle freeze-thaw lysis of an 
aliquot removed before any experimental manipulations; this value was used  in calculating 
the per cent of total platelet 5HT released into plasma.  Challenge substances included an 
Escherichia  coli endotoxin of the Boivin type (Difco, E. call endotoxin, lot 0127:B8)  in a  1 ROGER M.  DES  PREZ AND RICHARD E.  BRYANT  973 
mg per ml saline suspension, bovine topical thrombin in a 50 NIH unit per ml saline solution, 
and egg alb,  ml, in a  1 mg per ml saline solution.  All were added one part per nine parts 
platelet-rich plasma providing final concentrations of 100/~g endotoxin, 5 NIH units throm- 
bin, and 0.1 mg egg alb,mi, per ml of platelet-rich plasma (PRP). Preliminary experiments 
demonstrated the effectiveness  of these concentrations in  the experimental system under 
study. 
All glassware was siliconized (Siliclad, Clay-Adams, Inc., New York) and baked for 4 hr 
at 180°C to remove any contaminating bacterial pyrogen. 
TABLE  I 
Effect of Different Anticoagulants on Rdease of Platelet 5HT in Platdet-Rick Plasma from 
Rabbits Immunized with Egg Albumin 
Anticoagulant 
Heparin (100 #g per ml) 
Na citrate (0.38%) 
NaEDTA (0.1%) 
NaEDTA  (0.17%) 
Cha~enge 
Saline 
Endotoxin 
Antigen 
Saline 
Endotoxin 
Antigen 
Saline 
Endotoxin 
Antigen 
Saline 
Endotoxin 
Antigen 
0 min 
% 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
0 
PlateletSHTreleased  into 
plasma duringincubafion 
30 mln  ~ m~  90 rain 
%  %  % 
0  0  0 
33  88  85 
30  72  75 
0  0  0 
53  71  76 
0  0  0 
0  0  0 
18  75  106 
0  0  0 
0 
0  0  0 
0  0  0 
0  0  0 
RESULTS 
Fig. 1 compares the release of 5HT from platelet-rich plasma during incuba- 
tion with  endotoxin or antigen  (egg albumin)  with  that  observed during in- 
cubation with thrombin. As shown, release of 5HT after challenge with endo- 
toxin or antigen occurred after a  lag period and was progressive throughout 
the course of the incubation.  In contrast,  thrombin caused an immediate re- 
lease which was nonprogressive. Further, the effects of endotoxin and antigen 
were not inhibited in concentrations which entirely prevented release of 5HT 
by thrombin. 
In these two respects platelet damage produced by antigen and by endotoxin 
were similar and quite different from platelet damage produced by thrombin. 
However,  the  influence  of  various  anticoagulants  on  antigen-induced  5HT 
release and endotoxin-induced 5HT  release differed as illustrated in Table I. 974  BACTERIAL ENDOTOXIN  AND  RABBIT PLATELETS. IV 
These experiments showed that endotoxin caused release of 5HT from platelet- 
rich  plasma prepared  from  blood  containing  0.38%  sodium  citrate  or  0.1% 
sodium  EDTA  while  antigen-antibody  interaction  did  not.  They  further 
demonstrated another feature: when the concentration of sodium EDTA  was 
increased very slightly, neither endotoxin nor  antigen produced 5HT  release. 
PREINCUBATION  SEROTONIN  RELEASE 
DURING  INCUBATION 
A.  Citrate  Antigen 
(lOmM) 
B.  Saline  Antigen 
C.  Citrate  Saline 
(  I0  raM) 
D. 
20 Min 
Preincubation 
,t  I  Saline 
0  Min  15 Min  30 Min  60 Min 
0  0  0  0 
Citrate  0  20%  56%  53% 
( I0 raM) 
Saline  0  0  0  0 
Saline  Saline  Citrate  0  0  0  0 
(lOmM) 
9  PPP  ~!4  PRP 
m 
PLATELETS 
ADOED 
FIO. 2. Effect of addition of citrate before and after antigen-antibody interaction on re- 
lease of 5HT from subsequently added platelets. Heparinized platelet-rich plasma was pre- 
pared using blood of an immunized  rabbit, divided into 4 aliquots, platelets separated from 
each by centrifugatinn and the platelet buttons set aside. Citrate was added to two aliquots 
(A and C) and a control amount of saline to the other two (B and D) prior to addition of 
egg albumin (A and B) or control saline chaUenge (C and D). All samples were then prein- 
cubated for 20 min following which citrate (to B and D) and saline (to A and C) were added 
in reverse order. Platelet buttons were  then resuspended  in each sample,  incubation and 
rotation carried out, and release of 5HT measured over a further 60 min period of incubation. 
Platelet-rich plasma, PRP; and platelet-poor plasma, PPP. 
This difference in anticoagulant requirement suggested that the mechanism 
of antigen-induced and  endotoxin-induced platelet injury were  basically dif- 
ferent. However,  this difference was not observed when antigen and platelet- 
poor  immune  plasma  were  allowed  to  interact  in  the  absence  of  chelating 
agents. As shown in Fig. 2, preincubation of antigen in immune plasma in the 
absence of chelating agents resulted in the evolution of a  substance,  presum- ROGER  M. DES PREZ AND  RICHARD  E. BRYANT  975 
ably antigen-antibody complex,  which  then  caused  release  of platelet  5HT 
when citrate and platelets were readded to the plasma. This was accomplished 
by  temporarily  separating  the  platelets  from  heparinized  immune  plasma, 
incubating for a  20 mln period, then adding citrate, and finally resuspending 
platelets in the plasma.  Control specimens received citrate before this period 
of preincubatlon. Thus, all aliquots were similar except for the timing of citrate 
addition. When further incubation of these plasmas was carried out after re- 
TABLE II 
Effect  o.f Prdncubation  of Antigen*  on  Rdease  of Platdet 5HT from Immune Platelet-Ri~h 
Plasma in Different Anticoagulants 
Anticoagulant  Challenge  Release of platelet 5HT 
Heparin (100 ttg per ml) 
Na citrate (21.5 m-)§ 
NaEDTA (4.5 m~s) § 
NaEDTA (7.5 raM)§ 
Saline 
Endotoxin 
Antigen 
Prdncuba~d antigen~ 
Saline 
Endotoxin 
Antigen 
Prei~cubated antigen~ 
Saline 
Endotoxin 
Antigen 
Prdncubated antigen 
Saline 
Endotoxin 
Antigen 
Prdncubated antigen  ~ 
0 
+ 
+ 
+ 
0 
+ 
0 
+ 
0 
+ 
0 
+ 
* Egg albumin in platelet-rich plasma obtained from immunized rabbits. 
$ Egg albumin preincubated with heparinized platelet-poor plasma obtained from an 
immunized rabbit prior to additional citrate or NaEDTA and resuspension of platelets. 
§ Millimolarity of chelating agent in plasma. 
suspension of platelets, tubes in which antigen and antibody were preincubated 
in the temporary absence of citrate had come to resemble those which contained 
endotoxin.  In  such  systems,  release of platelet  5HT then took place in the 
presence of citrate  (Table II).  Fig.  3  shows that  the capacity of antigen to 
release 5HT in the presence of citrate was acquired within 10 rain preincuba- 
tion,  was  maximum at  60 rain,  and  deteriorated slightly with longer prein- 
cubation. 
In considering the reasons for the differences observed, the relative concen- 976  BACTERIAL  ENDOTOXIN  AND  RABBIT  PLATELETS.  IV 
trations  of ionized divalent cations in  the  solutions utilized were  examined. 
Table  III  compares  the  ionized  divalent  cation  concentrations  of  the  anti- 
coagulant solutions used. Normal rabbit plasma magnesium and calcium con- 
centrations have been found to average 1.01  nax  (0.84  to  1.22  m~)  and 3.84 
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FIG. 3. Development of citrate resistant 5HT releasing capacity during preincubation of 
antigen in  heparinized platelet-poor plasma  (PPP)  from  immuniT.ed rabbit. Afiquots  of 
hepm~nized platelet-rich plasma were  prepared, the platelets separated by centrifugation, 
and antigen (0.1 mg egg albumin per ml plasma) added to each tube. In the experiment de- 
picted in A, citrate (10 raM) was added to the first tube before antigen challenge, to the second 
after 10 rain preincubatien, to the third after 20 rain, and in like manner to successive sam- 
ples at 10-rain intervals throughout a 60 rain period of preincubation. Saline was added to the 
last sample as a control. After preincubation, platelets were resuspended  in all aliquots and 
release of 5HT determined after 60 rain further incubation. Per cent 5HT release is repre- 
sented on the ordinate, time of preincubation before addition of citrate on the abscissa. The 
experiment depicted in B focuses on the development of 5HT-releasing  capacity during the 
first 10 rain of preincubatien. The experiment depicted in C demonstrates the effects of more 
extended preinenbation. 
xnM (2.6 to 5.0 nm)  respectively (13).  Since heparin is not a  chelating agent, 
these  concentrations  can  be  presumed  to  be  present  in  heparinlzed plasma. 
The plasma molar concentration of citrate in blood anticoagulated with 0.38 % 
sodium citrate  exceeds the  combined plasma  concentrations  of  calcium and 
magnesium.  However,  citrate is  a  relatively weak ligand  (14),  and  one  can ROGER  M. DES PREZ AND  RICHARD  E. BRYANT  977 
calculate  that citrated plasma contains approximately 0.1 n~ concentrations 
of both ionized  calcium  and magnesium.  In contrast,  sodium EDTA binds 
both calcium and magnesium much more avidly (14). When present in plasma 
in amounts exceeding the combined concentrations  of calcium and magnesium, 
virtually no free divalent cation remains.  The commonly used concentration 
of 0.1%  EDTA represents  a  special case:  the molar plasma sodium EDTA 
concentration of 0.1% sodium EDTA blood (assuming an hematocrit of 40%) 
is slightly greater than the plasma concentration of calcium ion but less than 
the  combined  plasma  concentrations of calcium  plus  magnesium ion.  This 
excess of unbound divalent cation results in quite different concentrations of 
both free magnesium and free calcium ion; with respect  to concentration of 
TABLE HI 
Characteristics of Anticoa~ 
Concentration in whole 
blood 
Concentration  in plasma* 
pK calclumt 
Plasma ionized calcium  § 
pK magnesium~ 
Plasma ionized  magnesium§ 
Heparin 
30-100 #g/ml 
50-166  pg/ml 
3.8 mx¢l] 
1.2 mm[] 
~lanl Solutions Employed 
Na citrate  NaEDTA 
(0.38%)  (0.1%) 
12.9 mu  2.7 mM 
21.5 ms*  4.5 ms* 
3.22  10.59 
0.1 mx~  0.01 ms* 
3.20  8.69 
O.lmM  0.6 m,a 
NaEDTA 
(o.17%) 
4.5 mm 
7.5 m~ 
10.59 
<0.000O001  m- 
8.69 
<0.0O0001  m~r 
* Plasma concentration =  concentration  in whole blood X  100/(10o-hematocrit) using 
hematocrit ffi 40%. 
J: Reference  14. 
§ Approximate  values calculated  from * and ]1. 
Jl Mean values from reference  13. 
nonchelated divalent cations,  0.1%  sodium EDTA blood  resembles  citrated 
blood much more closely than it resembles 0.17 % sodium EDTA blood. 
By comparing Tables II and HI the divalent ion requirements of these three 
types of platelet injury can be partially defined. Interaction of antigen and 
antibody resulting in release of platelet 5HT requires more divalent cation than 
is furnished in citrated plasma or in plasma prepared from 0.1% sodium EDTA 
blood. These plasmas however do furnish sufficient divalent cation to support 
release  of platelet 5HT by endotoxin.  Preincubation of antigen in immune 
heparinized plasma converts the system to one which then resembles endotoxin 
in its reactivity in either citrated or 0.1% sodium EDTA plasma. When larger 
concentrations of sodium EDTA are used the resultant plasma does not con- 
tsin sufficient free divalent cation to support any of these reactions. 978  BACTERIAL  ENDOTOXIN  AND  RABBIT  PLATELETS.  IV 
DISCUSSION 
The present studies confirm the fact that the  interaction of endotoxin and 
platelets has a specific divalent ion requirement. Parallel studies using glycogen 
have demonstrated that platelet damage induced by this particulate agent has 
identical  divalent  ion  requirements.  Moreover neither  of  these  two  types  of 
platelet  damage are  inhibited  by heparin and  both have similar lag periods. 
For reasons to be discussed below, we have come to believe that these reactions 
may represent platelet phagocytosis of particulate matter. 
Platelet damage produced by addition of antigen to immune platelet-rich plasma 
requires  considerably  more  free  divalent  cation  than  necessary  for  the  platelet- 
endotoxin interaction.  However, preincubation  of  antigen  in  immune plasma con- 
taining no chelating agent converts the system to one which  then demonstrates the 
same divalent ion requirements as the endotoxin-platelet interaction. It seems reason- 
able to suggest that during this period of preincubation, antigen and antibody interact 
with complement to evolve antigen-antibody complexes  which  then interact as par- 
tides with platelets. Siqueira  and Nelson have in similar fashion defined  two phases 
of antigen-antibody-induced platelet injury (9). The first phase, during which antigen 
and antibody were incubated together, was inhibited by citrate and other chelating 
agents. The second phase, which occurred during incubation of this mixture with plate- 
lets, was found to be active in the presence of citrate. These authors presented con- 
siderable  evidence suggesting  that  the  heat-labile  plasma factors required  for  the 
second  phase  of  this  interaction  are  not  identical  with  complement.  In  contrast, 
Gocke has clearly demonstrated the participation of complement in the production of 
platelet injury by soluble antigen and antibody (15). Coupling  these two studies with 
the present data one can construct the following thesis: antigen, antibody, and com- 
plement interact  in  the  presence of physiologic  concentrations  of ionized  divalent 
cation to form a complex which then can react with platelets in a fashion not involv- 
ing further participation of complement and requiring definite  but much smaller con- 
centrations of divalent cation such as are provided in citrated plasma. The reaction 
between  endotoxin  and  platelets  requires  heat-labile plasma factors which  in  like 
manner do not appear to be complement (16, 17). Current studies are attempting to 
compare these factors with those required for the interaction of preformed antigen- 
antibody complexes with platelets. 
Recent studies by Movat and associates offer some support for the thesis that both 
endotoxin and antigen-antibody complexes behave as particles and that platelet in- 
jury produced by these substances is secondary to phagocytosis (18, 19). These au- 
thors have shown that platelets ingest latex particles, ferritin-antiferritin complexes, 
and other particulate materials. These platelet-particle interactions were independent 
of complement, produced release of platelet histamine and 5HT, and resulted in plate- 
let degranulation. Since 5HT is principally granule-associated in the platelet (20, 21), 
it can be perhaps regarded as a  component of platelet lysosomes.  Thus in many re- 
spects platelet-particle  interactions  result  in  a  series  of  events  analogous  to  that 
known to occur during the course of leukocyte phagocytosis (22). 
The question of the physiologic  importance of platelet phagocytosis in infectious ROGER  ~. DES PREZ AND  RICHARD E. BRYANT  979 
diseases merits examination. A series of clinical observations suggests that the plate- 
let may be involved in a variety of septicemic states.  Diseases such as subacute bac- 
terial  endocarditis  (23), malaria (24), Rocky Mountain spotted fever  (25), typhoid 
fever  (26), Gram-negative  septicemias  (27), Dengue  fever  (28), and meningococcal 
infections  (29) have been  noted to  be  associated  with  thrombocytopenia.  Conse- 
quences of overwhelming sepsis such as renal  cortical  necrosis and adrenal  hemor- 
rhagic thrombosis of the Waterhouse-Friderichsen type have been attributed to intra- 
vascular coagulation (30-33) and may well evolve in part at least from platelet injury. 
In like manner many of the effects of immunologic injury seem to implicate plate- 
lets. Platelet aggregation and release of vaso-active amines are characteristic  features 
of anaphylaxis.  Recent analyses of both experimental  and clinical acute glomerular 
nephritis suggest that the kidneys may he injured in these conditions by fibrin gener- 
ated elsewhere in the circulation  (34, 35), possibly as a result of partide-platelet or 
immune complex-platelet interactions. 
An hypothesis integrating these various considerations views the platelet as 
a  participant in the earliest phases of blood stream  clearance of a  variety of 
particulate and macromolecular materials (36).  It seems reasonable from this 
point of view that some of the manifestations of systemic infection may be 
consequences of the normal operation of this clearance mechanism in circum- 
stances in which the amount of material to be removed is quite large. Within 
this framework, some manifestations of immunologic injury can be regarded 
as consequences of a special form of particle clearance requiring the interaction 
of antigen,  antibody, and  complement so  that  the  foreign protein  may be 
recognized and treated as a particle. 
SUMMARY 
The divalent ion requirements of rabbit platelet injury by endotoxin have 
been defined by the use of various anticoagulant solutions and have been com- 
pared to the divalent ion requirements of platelet injury produced by addition 
of antigen to immune platelet-rich plasma. The endotoxin-platelet interaction 
takes place in citrated blood. Platelet damage by antigen is inhibited by citrate, 
but preincubation of antigen and immune platelet-poor plasma in the absence 
of citrate results  in  a  substance,  presumably antigen-antibody complement 
complex, which then does injure platelets in the presence of citrate. Neither 
endotoxin nor preincubated antigen injures platelets in the presence of sodium 
EDTA in concentrations sufficient to interact with all divalent cations present 
in plasma. 
These observations have been interpreted by viewing the platelet-endotoxin 
interaction as a  consequence of platelet phagocytosis of endotoxin, a reaction 
not requiring complement but requiring definite small concentrations of diva- 
lent cations. The interaction of antigen and platelets is regarded as a two phase 
reaction, the first requiring the participation of complement and concentrations 980  BACTERIAL ENDOTOXIN AND RABBIT PLATELETS. IV 
of divalent cation larger than those provided in citrated plasma,  the second 
requiring smaller concentrations of divalent cation, no further participation of 
complement, and  active in  citrated plasma.  This second phase is regarded as 
representing platelet phagocytosis of immune complexes. 
The technical assistance of Mr. James E. Johnson is most gratefully acknowledged. 
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